PA
PAHC
Market ClosedPhibro Animal Health Corporation
US
2.48K employees
CEO: Daniel Bendheim
Founded: 2014
$35.24
+$0.00(+NaN%)
Market Cap
1.43B
Beta
0.46
52W Range
N/A
Dividend Yield
1.36%
PAHC Price Chart
Historical price performance
Loading MCI price data...
MarketCI Investment Signals
AI-synthesized investment signal for PAHC built from valuation, fundamentals, sentiment, and risk models
Investment Signal
HoldPass %
57.14%
Score
4/7
Fair Value Estimate
Cash flow analysis • Multiple methods
-$13.71
AI Price Target
Machine learning • Price prediction
$33.93
Market Sentiment
News & social media analysis
0.00
Value Investor Price
Classic value analysis
$10.91
Financial Health
Bankruptcy risk assessment
3.03
Quality Score
Financial strength rating
6.00
AI Investment Grade
Deep analysis of filings & news
75.00
Key Investment Highlights
Important factors affecting PAHC investment thesis
Due Diligence Analysis
Investment criteria assessment and scoring
Overall Assessment
61.90% Good
Conditions Met
26.00/42.00
Due Diligence Score
61.90%Due Diligence Conditions
Investment analysis conditions and results
Pass | |
Pass | |
Pass | |
Pass | |
Pass | |
Fail |
Showing 1 to 6 of 46 conditions
Latest News
Recent news and updates for PAHC
No recent news available for PAHC
Core Financials
Loading financial data for PAHC...
Explore PAHC
PAHC in the Healthcare
Small Cap